Dashboard
Manage Tickers

ABEO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

abeona-therapeutics-announced-that-its-abo-503-gene-therapy-for-x-linked-retinoschisis-has-been-selected-to-participate-in-fda-rare-disease-endpoint-advancement-pilot-program
Abeona Therapeutics Announced That Its ABO...
10/13/2025 11:34:10

ABO-503 is composed of a functional human RS1 gene packaged in the novel AIM™ capsid AAV204. ABO-503 has shown preclinical effi...

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
10/13/2025 11:18:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 12:13:30

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
08/18/2025 11:08:25

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

oppenheimer-maintains-outperform-on-abeona-therapeutics-raises-price-target-to-20
Oppenheimer Maintains Outperform on Abeona...
08/15/2025 14:35:36

Oppenheimer analyst Andreas Argyrides maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and raises the price tar...

abeona-therapeutics-q2-eps-171-beats-039-estimate
Abeona Therapeutics Q2 EPS $1.71 Beats $(0...
08/14/2025 11:40:05

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $...

ascellahealth-partnership-with--abeona-therapeutics-highlights-the-launch-commercialization-of-zevaskyn-an-fda-approved-cell-based-gene-therapy
AscellaHealth Partnership With Abeona The...
07/29/2025 14:04:45

BERWYN, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the...

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
07/16/2025 11:34:07

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

abeona-therapeutics-announced-activation-of-the-newest-qualified-treatment-center-for-fda-approved-zevaskyn-prademagene-zamikeracel-gene-modified-cellular-sheets
Abeona Therapeutics Announced Activation O...
07/15/2025 11:34:43

Core News & Articles
Bio-Techne's Simple Western Technology Uti...
07/14/2025 11:05:47

Bio-Techne Corporation (NASDAQ:TECH) today announced that its Simple Western™ Technology played a key role in supporting the FD...

hc-wainwright--co-reiterates-buy-on-abeona-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Abeo...
07/14/2025 10:49:32

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20...

abeona-therapeutics-nets-155m-from-voucher-sale
Abeona Therapeutics Nets $155M From Vouche...
07/02/2025 11:41:50

Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Vo...

abeona-therapeutics-announces-it-has-exercised-its-option-to-license-abeonas-patented-aav204-capsid-for-use-in-potential-gene-therapies
Abeona Therapeutics Announces It Has Exerc...
07/01/2025 11:33:41

Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona...

abeona-therapeutics-added-to-russell-2000-and-russell-3000-indexes-following-zevaskyn-fda-approval
Abeona Therapeutics Added To Russell 2000 ...
06/30/2025 11:35:54

abeona-announces-publication-of-phase-3-viital-study-in-the-lancet-highlighting-zevaskyns-impact-on-chronic-rdeb-wounds
Abeona Announces Publication Of Phase 3 VI...
06/24/2025 11:33:44

RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for ye...

oppenheimer-assumes-abeona-therapeutics-at-outperform-announces-price-target-of-19
Oppenheimer Assumes Abeona Therapeutics at...
06/02/2025 17:09:07

Oppenheimer analyst Andreas Argyrides assumes Abeona Therapeutics (NASDAQ:ABEO) with a Outperform rating and announces Price...

pdd-holdings-posts-weak-results-joins-ehang-holdings-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
PDD Holdings Posts Weak Results, Joins EHa...
05/27/2025 12:13:03

why-e2open-shares-are-trading-higher-by-25-here-are-20-stocks-moving-premarket
Why E2open Shares Are Trading Higher By 25...
05/27/2025 09:16:35

stifel-maintains-buy-on-abeona-therapeutics-lowers-price-target-to-20
Stifel Maintains Buy on Abeona Therapeutic...
05/16/2025 17:48:47

Stifel analyst Dae Gon Ha maintains Abeona Therapeutics (NASDAQ:ABEO) with a Buy and lowers the price target from $21 to $20.

abeona-therapeutics-q1-eps-024-beats-036-estimate
Abeona Therapeutics Q1 EPS $(0.24) Beats $...
05/15/2025 11:37:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION